by cwsadmin | Feb 9, 2024 | Uncategorized
Machine learning and artificial intelligence seem to have dipped into almost every industry in the world; fashion, marketing, manufacturing, engineering and even commercial real estate. So, while it’s not hard to fathom that machine learning could soon leak...
by cwsadmin | Jan 30, 2024 | Uncategorized
The quadrivalent human papillomavirus (qHPV) vaccine has demonstrated remarkable durability in preventing HPV-related diseases, even over a decade after administration. Long-term follow-up (LTFU) studies across diverse populations reaffirm its efficacy, safety, and...
by cwsadmin | Jan 2, 2024 | Uncategorized
Welcome to our deep dive on the ongoing breast cancer vaccine study, formally known as the “Multicenter Phase II Study of Vaccines to Prevent Recurrence in Patients With HER-2 Positive Breast Cancer”. This study is slated to conclude in 2026, and has...
by cwsadmin | Jan 2, 2024 | Uncategorized
Stated plainly by Adam Waickman, an accomplished immunologist at SUNY Upstate Medical University in Syracuse, slowing the dengue virus epidemic is going to take the international collaboration of drug development experts as well as every tool at their disposal. With...
by cwsadmin | Oct 13, 2023 | Uncategorized
Pharmacovigilance is an incredibly essential component of monitoring patient safety. One of the largest responsibilities of pharmacovigilance professionals is to observe adverse drug reactions (ADRs) and act in the best interest of the public. While the drug...
